Sims Tracy J, Kapoor Richa, Chinthammit Chanadda, Spaepen Erik
Eli Lilly and Company, Indianapolis, IN, USA.
Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, 46285, USA.
Diabetes Ther. 2025 Sep 8. doi: 10.1007/s13300-025-01786-9.
Weight and diabetes stigma among healthcare professionals (HCPs) may negatively impact treatment decisions, patient outcomes, and physician-patient interactions. We assessed the relationship between weight stigma, diabetes stigma, perceptions of healthcare quality, and avoidance of healthcare among adults with type 2 diabetes (T2D).
This observational, online survey-based study included 857 US adults with T2D. The survey included perceptions of patient-centered care with questions from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey, perceptions of provider communication with questions from the Diabetes Attitudes, Wishes, and Needs (DAWN) study, de novo questions assessing participants' interactions with HCPs, perceived weight stigma and discrimination, and healthcare quality/avoidance delay questions. Mean scores were reported for patient-reported outcome measures: Modified Weight Bias Internalization Scale, Weight Self-Stigma Questionnaire, and Type 2 Diabetes Stigma Assessment Scale. Additional analyses were based on CAHPS, DAWN, and healthcare quality/avoidance responses.
High degrees of weight bias internalization (WBI) and diabetes stigma were observed among participants dissatisfied with their HCP's overall involvement in their care and those who perceived judgment from the HCP because of their weight. Participants with high degrees of WBI and diabetes stigma were more likely to avoid seeking care, felt uncomfortable with body examinations, and rarely underwent regular health checkups. Those who had suboptimal interactions with their HCPs reported greater stigma.
Increasing awareness among HCPs regarding weight and diabetes stigma and promoting compassionate communication in healthcare interactions may help diminish these forms of stigma, thereby potentially improving health outcomes for people with T2D.
医疗保健专业人员(HCPs)中存在的体重和糖尿病污名化可能会对治疗决策、患者治疗效果以及医患互动产生负面影响。我们评估了2型糖尿病(T2D)成年患者的体重污名、糖尿病污名、对医疗质量的认知与避免就医之间的关系。
这项基于在线调查的观察性研究纳入了857名美国T2D成年患者。该调查包括来自医疗服务提供者和系统消费者评估(CAHPS)调查中关于以患者为中心的护理认知的问题、来自糖尿病态度、愿望和需求(DAWN)研究中关于提供者沟通的问题、评估参与者与HCPs互动的全新问题、感知到的体重污名和歧视,以及医疗质量/避免就医延迟问题。报告了患者报告结局指标的平均得分:改良体重偏见内化量表、体重自我污名问卷和2型糖尿病污名评估量表。其他分析基于CAHPS、DAWN以及医疗质量/避免就医的回答。
在对HCPs对其护理的总体参与不满意的参与者以及因体重而感受到HCPs评判的参与者中,观察到了高度的体重偏见内化(WBI)和糖尿病污名。WBI和糖尿病污名程度高的参与者更有可能避免就医,对身体检查感到不适,并且很少进行定期健康检查。那些与HCPs互动不佳的参与者报告的污名感更强。
提高HCPs对体重和糖尿病污名的认识,并在医疗互动中促进富有同情心的沟通,可能有助于减少这些形式的污名,从而有可能改善T2D患者的健康结局。